Teva Pharmaceutical Industries trades -15.56% away from its average analyst target price of $21.14 per share. The 7 analysts ...

Emmerich succeeds Franz Cerwinka, who will serve as a senior advisor until March 2025 to ensure a smooth transition. Xylem's ...

Lundbeck, a biopharmaceutical company based in Denmark, has announced the acquisition of Longboard Pharmaceuticals in a ...

Telefonaktiebolaget LM Ericsson (publ), together with its subsidiaries, provides mobile connectivity solutions for telcom ...

After this morning's 6.5% surge to $72.24 per share, Charles Schwab might just keep moving past its target price of $72.67.

The market seems to share this optimistic view, since JD.com has a short interest of only 3.3% (this is the percentage of the ...

Consol Energy Inc., based in Canonsburg, Pennsylvania, is a producer and exporter of high-BTU bituminous thermal coal and ...

For American Tower, average sales revenue over the last 5 years has been $10.93 Billion, so in the context of the Graham ...

Spyre Therapeutics, a clinical-stage biotechnology company, has announced the expected acceleration of its clinical timelines ...

UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at ...

The establishment of the 51% / 49% joint venture is expected to occur by the end of October 2024, pending certain conditions ...

The P/B ratio for Wipro is 0.04, compared to its sector average of 3.91 and the S&P500's average P/B of 4.74. The most common ...